FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

NCT02607449 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
344
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Scientific Center for Anti-infectious Drugs, Kazakhstan

Collaborators